Patients News | pharmaphorum

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

AZ COVID jab efficacy debate is hindering EU’s vaccine drive

The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to undermine the EU’s vaccination targets.

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Zynteglo halt re-ignites viral vector safety concerns; analy...

Bluebird Bio’s decision to hit pause on the launch of Zynteglo for beta thalassaemia after two cases of cancer were seen in a clinical trial could see fears over the safety of viral vectors

News

Scientists make case for one dose of Pfizer’s COVID jab to s...

Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as this would increase the number of people that can be protected while suppl

News

UK will start first COVID-19 challenge study “within a month...

Sometime within the next few weeks, young and healthy volunteers will be deliberately exposed to the COVID-19 coronavirus in the UK in what looks set to be the first study of its type world

News

Senior woman in medical mask with social worker visiting her at home

COVID-19 increased demands on carers' wellbeing, study finds

COVID-19 has increased demands on informal carers and severely increased demands on their mental, physical and financial wellbeing, according to a global study.

News